Clinical trial
SENOVIE France - Therapeutic Mobility and Breast Cancer
NCT06503393
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedSENOVIE France - Therapeutic Mobility and Breast Cancer
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancer Femaleunresolved
Interventions
Sponsors & collaborators
Institut de Recherche pour le Developpementlead sponsor
Saint-Louis Hospital, Paris, Francecollaborator
Centre Hospitalier de Saint-Deniscollaborator
National Cancer Institute, Francecollaborator
The French Collaborative Institute on Migrationscollaborator
Ceped UMR 196collaborator
Université Paris Citécollaborator
Hospital Avicennecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06503393 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.